National Heart, Lung, and Blood Institute: Advance Research on Lung Disease Therapies (U01)

Opportunity ID: 45439

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-HL-10-003
Funding Opportunity Title: Phase II Clinical Trials of Novel Therapies for Lung Diseases (U01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 6
Assistance Listings: 93.233 — National Center on Sleep Disorders Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Feb 23, 2009
Last Updated Date:
Original Closing Date for Applications: Sep 15, 2010
Current Closing Date for Applications: Sep 15, 2010
Archive Date: Oct 16, 2010
Estimated Total Program Funding: $40,600,000
Award Ceiling: $800,000
Award Floor:

Eligibility

Eligible Applicants: Small businesses
City or township governments
Public housing authorities/Indian housing authorities
Native American tribal governments (Federally recognized)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
Private institutions of higher education
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
County governments
Native American tribal organizations (other than Federally recognized tribal governments)
State governments
Special district governments
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: Purpose. This Funding Opportunity Announcement (FOA) issued by the National Heart, Lung, and Blood Institute, National Institutes of Health, solicits grant applications from institutions/organizations to conduct proof-of- concept Phase II clinical trials that test a novel intervention for a lung disease or a cardiopulmonary disorder from sleep that have the potential to significantly change clinical management. In addition, each application must include at least one ancillary study tightly related to the clinical question.
Mechanism of Support. This FOA will utilize the NIH cooperative agreement (U01) grant mechanism.
Funds Available and Anticipated Number of Awards. The NHLBI intends to commit up to $40,600,000 (total costs) over 4 years. It is anticipated that up to two awards will be made for each of 3 receipt dates for a total of four to six awards.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-10-003.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *